Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders (JAKarta Study)

NCT07261891 is registered in ClinicalTrials.gov with prof. dr. Rik Schrijvers as lead sponsor.

NCT NCT07261891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07261891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders (JAKarta Study)
Lead sponsor
prof. dr. Rik Schrijvers
Phase
Not applicable
Overall status
Recruiting
Start date
November 21, 2024
Completion date
December 1, 2030
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary immunodeficiency diseases (pid)